Medical devices, healthcare technology and the business of care
510(k) clearance · K261623

EchoPAC Software Only / EchoPAC Plug-in (v211)

GE Medical Systems Ultrasound and Primary Care Diagnostics · Decision date Sep 16, 2026

MEDTECHLEDGER EXPLANATIONK261623

What did the FDA decide?

FDA recorded a substantially equivalent (SESE) decision on September 16, 2026 for K261623, EchoPAC Software Only / EchoPAC Plug-in (v211), submitted by GE Medical Systems Ultrasound and Primary Care Diagnostics under regulation 21 CFR 892.2050 with product codes QIH and LLZ, in the Radiology specialty. SESE is a 510(k) clearance to market, not a premarket approval. The FDA database lists the application as received May 15, 2026, a traditional submission not reviewed by a third party, with a Predetermined Change Control Plan authorized.

The submission describes software for diagnostic review and analysis of ultrasound images, patient record management and reporting, offered as software installed on customer PC hardware or as a plug-in hosted on a PACS workstation, with DICOM transfer over a LAN. The summary names EchoPAC Software Only / EchoPAC Plug-in (K251342) and Vivid E95 (K220882) as primary predicates and states the device uses the same fundamental scientific technology. The clearance letter's stated receipt date of August 18, 2026 conflicts with the database's May 15, 2026; the record does not resolve this.

Regulatory pathway
510(k) premarket notification
Clinical specialty
Radiology
Decision date
Sep 16, 2026

FDA source record · MedtechLedger’s explanation describes the recorded change.

Regulatory record facts

Identifier
K261623
Regulatory pathway
510(k) premarket notification
Product code
QIH
Decision code
SESE
Decision date
Sep 16, 2026
Source update
Nov 9, 2026
Original record
Open FDA source record

About this medical device

FDA device category: Automated Radiological Image Processing Software.

Product code
QIH
FDA device class
2

FDA decision timeline

  1. K261623 received

    Application receipt date recorded by FDA.

  2. K261623 · FDA decision

    SESE

Related devices and submissions

Explore the linked device profile

Other records with product code QIH

Product / regulatory recordCompanyPathwayDecision dateSource
Clever OneK260372
Ewoosoft Co., Ltd.510(k) clearanceNov 4, 2026FDA
Peek Health, S.A.510(k) clearanceNov 4, 2026FDA
AVICENNA.AI510(k) clearanceOct 19, 2026FDA
UAB Ligence510(k) clearanceOct 7, 2026FDA
NeuroDRK262134
Deep Reasoning Ai, Inc.510(k) clearanceOct 7, 2026FDA

A shared product code identifies a classification relationship; it does not establish clinical equivalence.

Regulatory context

A 510(k) submission seeks a finding of substantial equivalence to a legally marketed device. A clearance and a PMA approval are different regulatory decisions.

Read our guide to FDA clearance and approval · FDA’s explanation of this pathway

Manufacturer intelligence

GE Medical Systems Ultrasound and Primary Care Diagnostics

Headquarters
Not reported
Brand website
Not reported
FDA applicant address
Waukesha, WI

Sources and methodology

FDA fields and approval-order wording are presented as source information. MedtechLedger explanations are identified separately and describe the scope of the recorded decision. Indications from an original PMA are historical unless confirmed against subsequent labeling and supplements.

How we use FDA records